Compositions having improved bioavailability of therapeutics
US12226484B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2023 |
| Grant date | Feb 18, 2025 |
| Priority date | — |
| Expiry date | Oct 16, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present specification discloses pharmaceutical composition disclosed herein comprises one or more therapeutic compounds, one or more glycerolipids, and one or more digestion enhancers. The disclosed glycerolipids comprise one or more hard fats and one or more liquid fats. The disclosed digestion enhancers comprise one or more bile acids, one or more phospholipids, one or more free C14-24 fatty acids, one or more free C14-24 fatty acid surfactants, or any combination thereof. The present specification also discloses methods and procedures to formulate the disclosed one or more therapeutic compounds into the disclosed pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.